The Bench to Bedside Initiative (formerly, Entrepreneurship and Venture Capital Club at Weill Cornell) was founded as a club in 2010 and has resulted in the creation of numerous seed-funded biotech startups. Our mission is to help scientists and clinicians in our community translate their ideas into products that can help patients. Current Members
Sarah Kishinevsky, PhD Candidate, President and Co
-Founder
Benjamin J. Burnett, PhD Candidate, Class Liasion
Denisse Izquierdo, PhD Candidate, Club Liaison
Joel Schrock, PhD, Johnson MBA School Liaison
Bench to Bedside Initiative is also offered as a 1 credit elective course through Cornell and Rockefeller University. Bench to Bedside, hosted by the Bench to Bedside Initiative and the Sanders Tri-Institutional Therapeutics Discovery Institute, Inc., teaches basic financial analysis and principles of entrepreneurship. Lectures will cover evaluating the market potential of a technology, building basic financial models, funding mechanisms, and writing and presenting a business plan to potential investors. Lectures are open to members of Cornell University, Memorial Sloan Kettering Cancer Institute, and Rockefeller University. We welcome leaders in the local NYC healthcare and biotechnology sector.
